SEA VII Management, LLC - 08 Aug 2022 Form 4 Insider Report for Definitive Healthcare Corp. (DH)

Role
Director, 10%+ Owner
Signature
SEA VII MANAGEMENT, LLC, By: /s/ Carolina A. Picazo, Chief Administrative Officer & Chief Compliance Officer
Issuer symbol
DH
Transactions as of
08 Aug 2022
Net transactions value
-$50,064,000
Form type
4
Filing time
10 Aug 2022, 17:20:44 UTC
Previous filing
12 May 2022
Next filing
28 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DH Class B Common Stock Other -1,100,000 -4.6% 22,991,844 08 Aug 2022 See note F1, F2, F3
transaction DH Class A Common Stock Conversion of derivative security +1,100,000 +44% 3,608,971 08 Aug 2022 See note F1, F2, F3
transaction DH Class A Common Stock Sale $26,950,000 -1,100,000 -30% $24.50 2,508,971 08 Aug 2022 See note F3, F4
transaction DH Class B Common Stock Other -1,016,000 -4.4% 21,975,844 09 Aug 2022 See note F2, F3, F5
transaction DH Class A Common Stock Conversion of derivative security +1,016,000 +40% 3,524,971 09 Aug 2022 See note F2, F3, F5
transaction DH Class A Common Stock Sale $23,114,000 -1,016,000 -29% $22.75 2,508,971 09 Aug 2022 See note F3, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DH LLC Units of AIDH Topco, LLC Conversion of derivative security -1,100,000 -4.6% 22,991,844 08 Aug 2022 Class A Common Stock 1,100,000 See note F1, F2, F3
transaction DH LLC Units of AIDH Topco, LLC Conversion of derivative security -1,016,000 -4.4% 21,975,844 09 Aug 2022 Class A Common Stock 1,016,000 See note F2, F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 See Exhibit 99.1 for the text of footnote (1).
F2 See Exhibit 99.1 for the text of footnote (2).
F3 See Exhibit 99.1 for the text of footnote (3).
F4 See Exhibit 99.1 for the text of footnote (4).
F5 See Exhibit 99.1 for the text of footnote (5).
F6 See Exhibit 99.1 for the text of footnote (6).

Remarks:

Christopher T. Mitchell, a Managing Director of Spectrum and Jeffrey C. Haywood, a Managing Director of Spectrum (together, the "Spectrum Directors"), each serve on the board of directors of the Issuer, and have been deputized to represent the Reporting Persons on the board of directors. By virtue of the Spectrum Directors' representation, for purposes of Section 16 of the Securities Exchange Act of 1934, each of the Reporting Persons may be deemed directors by deputization of the Issuer. The Spectrum Directors have filed separate Section 16 reports disclosing securities of the Issuer that they may be deemed to beneficially own for Section 16 purposes.